Article Type
Changed
Fri, 07/01/2022 - 12:57

Key clinical point: Regular tea consumption shows a weak inverse association with risk for gastric cancer.

Major finding: Regular vs. nonregular tea drinkers had a significantly lower risk for gastric cancer (pooled odds ratio [OR] 0.91; 95% CI 0.85-0.97). Compared with nonregular tea drinkers, there was no difference in risk for gastric cancer in regular tea drinkers who consumed 1 to <2, 2 to <3, ≥3 cups (Ptrend = .27). A lower risk was observed in studies from China, Japan, and Iran (OR 0.62; 95% CI 0.48-0.81) and from China and Japan (OR 0.67; 95% CI  0.49-0.91).

Study details: A pooled analysis of 34 studies including 13,121 patients with gastric cancer and 31,420 control individuals from the StoP Project (a consortium of epidemiological studies on gastric cancer) dataset.

Disclosures: This study was supported by Associazione Italiana per la Ricerca sul Cancro and Italian League for the Fight Against Cancer. The authors declared no competing interests.

Source: Martimianaki G et al. Tea consumption and gastric cancer: A pooled analysis from the Stomach cancer Pooling (StoP) Project consortium. Br J Cancer. 2022 (May 24). Doi: 10.1038/s41416-022-01856-w

Publications
Topics
Sections

Key clinical point: Regular tea consumption shows a weak inverse association with risk for gastric cancer.

Major finding: Regular vs. nonregular tea drinkers had a significantly lower risk for gastric cancer (pooled odds ratio [OR] 0.91; 95% CI 0.85-0.97). Compared with nonregular tea drinkers, there was no difference in risk for gastric cancer in regular tea drinkers who consumed 1 to <2, 2 to <3, ≥3 cups (Ptrend = .27). A lower risk was observed in studies from China, Japan, and Iran (OR 0.62; 95% CI 0.48-0.81) and from China and Japan (OR 0.67; 95% CI  0.49-0.91).

Study details: A pooled analysis of 34 studies including 13,121 patients with gastric cancer and 31,420 control individuals from the StoP Project (a consortium of epidemiological studies on gastric cancer) dataset.

Disclosures: This study was supported by Associazione Italiana per la Ricerca sul Cancro and Italian League for the Fight Against Cancer. The authors declared no competing interests.

Source: Martimianaki G et al. Tea consumption and gastric cancer: A pooled analysis from the Stomach cancer Pooling (StoP) Project consortium. Br J Cancer. 2022 (May 24). Doi: 10.1038/s41416-022-01856-w

Key clinical point: Regular tea consumption shows a weak inverse association with risk for gastric cancer.

Major finding: Regular vs. nonregular tea drinkers had a significantly lower risk for gastric cancer (pooled odds ratio [OR] 0.91; 95% CI 0.85-0.97). Compared with nonregular tea drinkers, there was no difference in risk for gastric cancer in regular tea drinkers who consumed 1 to <2, 2 to <3, ≥3 cups (Ptrend = .27). A lower risk was observed in studies from China, Japan, and Iran (OR 0.62; 95% CI 0.48-0.81) and from China and Japan (OR 0.67; 95% CI  0.49-0.91).

Study details: A pooled analysis of 34 studies including 13,121 patients with gastric cancer and 31,420 control individuals from the StoP Project (a consortium of epidemiological studies on gastric cancer) dataset.

Disclosures: This study was supported by Associazione Italiana per la Ricerca sul Cancro and Italian League for the Fight Against Cancer. The authors declared no competing interests.

Source: Martimianaki G et al. Tea consumption and gastric cancer: A pooled analysis from the Stomach cancer Pooling (StoP) Project consortium. Br J Cancer. 2022 (May 24). Doi: 10.1038/s41416-022-01856-w

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan; Gastric Cancer, July 2022
Gate On Date
Wed, 06/22/2022 - 12:15
Un-Gate On Date
Wed, 06/22/2022 - 12:15
Use ProPublica
CFC Schedule Remove Status
Wed, 06/22/2022 - 12:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article